Donna L. Smith

London, ENG SE19RT, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Myostatin inhibition prevents skeletal muscle pathophysiology in Huntington's disease mice.

Myostatin inhibition prevents skeletal muscle pathophysiology in Huntington's disease mice.

Journal: Scientific reports
Published: August 16, 2017

Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell-type-specific.

Frequency of nuclear mutant huntingtin inclusion formation in neurons and glia is cell-type-specific.

Journal: Glia
Published: June 08, 2016

Correction: SIRT1 Activity Is Linked to Its Brain Region-Specific Phosphorylation and Is Impaired in Huntington's Disease Mice.

Correction: SIRT1 Activity Is Linked to Its Brain Region-Specific Phosphorylation and Is Impaired in Huntington's Disease Mice.

Journal: PloS one
Published: February 27, 2016

SIRT1 Activity Is Linked to Its Brain Region-Specific Phosphorylation and Is Impaired in Huntington's Disease Mice.

SIRT1 Activity Is Linked to Its Brain Region-Specific Phosphorylation and Is Impaired in Huntington's Disease Mice.

Journal: PloS one
Published: October 08, 2015

Dysfunction of the CNS-heart axis in mouse models of Huntington's disease.

Dysfunction of the CNS-heart axis in mouse models of Huntington's disease.

Journal: PLoS genetics
Published: April 08, 2014

Characterisation of immune cell function in fragment and full-length Huntington's disease mouse models.

Characterisation of immune cell function in fragment and full-length Huntington's disease mouse models.

Journal: Neurobiology of disease
Published: February 05, 2014

Dynamic recruitment of active proteasomes into polyglutamine initiated inclusion bodies.

Dynamic recruitment of active proteasomes into polyglutamine initiated inclusion bodies.

Journal: FEBS letters
Published: August 08, 2013

HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration.

HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration.

Journal: PLoS biology
Published: June 05, 2013

Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease.

Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 24, 2013

Rhodium-catalyzed [2 + 2] cycloaddition of ynamides with nitroalkenes.

Rhodium-catalyzed [2 + 2] cycloaddition of ynamides with nitroalkenes.

Journal: Organic letters
Published: September 08, 2012
Showing 1-10 of 10

Last Updated: 09/26/2026